Shirin Azizidoost, Fatemeh Khojasteh pour, Sajad Najafi, Farhoodeh Ghaedrahmati, Z. Nazeri, Dian Dayer, Zahra Shabani, Maryam Farzaneh, Ava Nasrolahi
{"title":"长非编码 RNA 在本质性高血压发病机制中的作用","authors":"Shirin Azizidoost, Fatemeh Khojasteh pour, Sajad Najafi, Farhoodeh Ghaedrahmati, Z. Nazeri, Dian Dayer, Zahra Shabani, Maryam Farzaneh, Ava Nasrolahi","doi":"10.2174/0115743624283095240308072648","DOIUrl":null,"url":null,"abstract":"\n\nHypertension, a condition characterized by elevated blood pressure, poses a significant medical risk, particularly in relation to the development of cardiovascular disease. The\npathogenesis of hypertension can be influenced by a combination of genetic and environmental\nfactors. Recent scientific studies have shed light on the involvement of long-non-coding RNAs\n(lncRNAs) in various diseases, including pulmonary arterial and essential hypertension. These\nlncRNAs have been found to play crucial roles at the transcriptional, post-transcriptional, and\npost-translational levels. By targeting endothelial cell proliferation, migration, apoptosis, and\nangiogenesis, lncRNAs can induce dysfunction in arterial endothelial cells, contributing to the\nprogression of hypertension-related pathological events. Therefore, the abnormal expression of\nlncRNAs has emerged as a significant factor in the understanding of essential hypertension and\nits associated mechanisms. To further our understanding, we conducted a comprehensive review\nfocusing on unraveling the functional roles of lncRNAs in essential hypertension.\n","PeriodicalId":10868,"journal":{"name":"Current Signal Transduction Therapy","volume":"38 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Role of Long Non-Coding RNAs in the Pathogenesis of Essential\\nHypertension\",\"authors\":\"Shirin Azizidoost, Fatemeh Khojasteh pour, Sajad Najafi, Farhoodeh Ghaedrahmati, Z. Nazeri, Dian Dayer, Zahra Shabani, Maryam Farzaneh, Ava Nasrolahi\",\"doi\":\"10.2174/0115743624283095240308072648\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nHypertension, a condition characterized by elevated blood pressure, poses a significant medical risk, particularly in relation to the development of cardiovascular disease. The\\npathogenesis of hypertension can be influenced by a combination of genetic and environmental\\nfactors. Recent scientific studies have shed light on the involvement of long-non-coding RNAs\\n(lncRNAs) in various diseases, including pulmonary arterial and essential hypertension. These\\nlncRNAs have been found to play crucial roles at the transcriptional, post-transcriptional, and\\npost-translational levels. By targeting endothelial cell proliferation, migration, apoptosis, and\\nangiogenesis, lncRNAs can induce dysfunction in arterial endothelial cells, contributing to the\\nprogression of hypertension-related pathological events. Therefore, the abnormal expression of\\nlncRNAs has emerged as a significant factor in the understanding of essential hypertension and\\nits associated mechanisms. To further our understanding, we conducted a comprehensive review\\nfocusing on unraveling the functional roles of lncRNAs in essential hypertension.\\n\",\"PeriodicalId\":10868,\"journal\":{\"name\":\"Current Signal Transduction Therapy\",\"volume\":\"38 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Signal Transduction Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0115743624283095240308072648\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Signal Transduction Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115743624283095240308072648","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
The Role of Long Non-Coding RNAs in the Pathogenesis of Essential
Hypertension
Hypertension, a condition characterized by elevated blood pressure, poses a significant medical risk, particularly in relation to the development of cardiovascular disease. The
pathogenesis of hypertension can be influenced by a combination of genetic and environmental
factors. Recent scientific studies have shed light on the involvement of long-non-coding RNAs
(lncRNAs) in various diseases, including pulmonary arterial and essential hypertension. These
lncRNAs have been found to play crucial roles at the transcriptional, post-transcriptional, and
post-translational levels. By targeting endothelial cell proliferation, migration, apoptosis, and
angiogenesis, lncRNAs can induce dysfunction in arterial endothelial cells, contributing to the
progression of hypertension-related pathological events. Therefore, the abnormal expression of
lncRNAs has emerged as a significant factor in the understanding of essential hypertension and
its associated mechanisms. To further our understanding, we conducted a comprehensive review
focusing on unraveling the functional roles of lncRNAs in essential hypertension.
期刊介绍:
In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.
The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.